fbpx

Bedtime Lighting May Cause Diabetes

Deadly Combination of Depression and Diabetes

Exposure to bright artificial light between dusk and bedtime can reduce the quality of your sleep and increase the risk of diabetes and high blood pressure.

A new study by researchers of Harvard Medical School has found that exposure to bright room light before sleep shortened the duration of melatonin production by about 90 minutes.  Room light during sleep hours strongly suppressed melatonin by more than 50 percent.  Melatonin, a physiology-regulating hormone made at night in the brain is known to regulate the sleep-wake cycle, blood pressure, and body temperature.

The research monitored blood plasma melatonin every 30~60 minutes in 116 healthy participants aged 18 to 30 who were exposed to bright or dim light for eight hours before bedtime.  The study is scheduled for publication in the March issue of the Journal of Clinical Endocrinology & Metabolism.

“Given that chronic light suppression of melatonin has been hypothesized to increase relative risk for some types of cancer and that melatonin receptor genes have been linked to type 2 diabetes, our findings could have important health implications for shift workers who are exposed to indoor light at night over the course of many years,” said the lead author Dr. Joshua Gooley, of Brigham and Women’s Hospital and Harvard Medical School.

 

The new Eleotin LBM with mind-soothing, antidepressant efficacy is soon to be granted an approval from Health Canada.  Eleotin is the only known 100% natural normalizer of long term chronic metabolic disorders such as diabetes.  Eleotin has been approved in many countries.
                          

For more information, visit
www.eastwoodcompanies.com www.medireport.com 
Or email us at info@eastwoodcos.com 

Canada Leads the Fight against Diabetes

Canada Leads the Fight against Diabetes

One of the greatest gifts Canada has given the world is Dr. Frederick Grant Banting’s research that led to the discovery of insulin in 1921.  In commemoration of the 90th anniversary of his achievement, a three-metre high sculpture has been unveiled at Banting House National Historic Site of Canada located in London, Ontario.

“Canada is at the forefront of the effort to improve the quality of life for the millions of people around the world living with diabetes.  We wouldn’t be where we’re at had it not been for Banting’s brilliant idea,” said Michael Cloutier, President of the Canadian Diabetes Association.

He added that the sculpture would serve as a symbol of the ongoing research conducted around the world in search of a cure for diabetes, and how the world continues to look to Canada as world-class experts in the field of diabetes management and research.

Recently, Banting has been voted the fourth greatest Canadian of all time in CBC’s The Greatest Canadian Contest.  He also received Maclean’s magazine’s prestigious title of greatest Canadian innovators for discovering insulin.  At the time of his discovery, diabetes was a slow but sure death sentence that generally affected people under the age of 30.  For delivering hope to them, he became the youngest person ever to receive the Nobel Prize in Medicine in 1923.

Many Canadian researchers have carried on the proud Canadian legacy of pioneering breakthroughs in diabetes research.  Following in the footsteps of Dr. Banting, scientists are working towards improving health for people suffering from the global diabetes epidemic.

Among them, one who has played a pivotal role in changing the way diabetes is treated is presented the Frederick G. Banting Award.  The annual award is paving the road to diabetes cures by recognizing a significant contribution to either preventing diabetes or to improving the quality of life of individuals affected by diabetes.

 

The new Eleotin LBM with mind-soothing, antidepressant efficacy is soon to be granted an approval from Health Canada.  Eleotin is the only known 100% natural normalizer of long-term chronic metabolic disorders such as diabetes.  Eleotin has been approved in many countries.
                          

For more information, visit
www.eastwoodcompanies.com www.medireport.com 
Or email us at info@eastwoodcos.com 

Canada’s Contributions to Diabetes Research

Canada’s Contributions to Diabetes Research

When 11-year-old Elizabeth Hughes was diagnosed with diabetes in 1919, it was equivalent to a death sentence.  She was not expected to live beyond her 14th birthday.  At that time, the only known method of prolonging the life of diabetics was to put the patient on a salad-based starvation diet devoid of sugar and starch with only the minimum calories needed to survive.

In the process, Elizabeth came to weigh just 45 pounds of skin and bones three years after her initial diagnosis.  But she was lucky enough to be one of the first patients to try the new revolutionary treatment Dr. Frederick Banting of the University of Toronto developed by isolating insulin from pancreatic hormones.  She lived up to be 74 years old, and Dr. Banting’s discovery has been called one of the most important scientific advances of the 20th century.

The story of Elizabeth Hughes and diabetes research were brought to light by recently published book ‘Breakthrough: Elizabeth Hughes, the Discovery of Insulin, and the Making of a Medical Miracle’ by Thea Cooper and Arthur Ainsberg.  It details the great moment of medical history, those who made it happen and those whose lives were changed forever.

Dr. Banting won the Nobel Prize in Medicine in 1923.  Since then, Canada has been the leading country in the area of diabetes research.  Banting’s name was immortalized as his birthday has been taken as World Diabetes Day, November 14th.

Today, we know that the injectable insulin was not a fundamental cure for diabetes.  Even with its symptoms brought under control, diabetes has become as epidemic as to be called ‘The Plague of Modern Times.’  It not only destroys the lives of patients and their families but also causes a financial catastrophe for individuals and society.

According to the American Diabetes Association, 23.6 million children and adults in the United States, 7.8% of the population, has diabetes.  Of that amount, 17.9 million people are diagnosed, and 5.7 million people go undiagnosed.  Additionally, 57 million people have pre-diabetes, and each year 1.6 million new cases of diabetes are diagnosed in people aged 20 years and older.

The need for the safe and permanent diabetes cure is getting more essential for the health and well being of people than ever.

Eleotin is the only known 100% natural normalizer of long-term chronic metabolic disorders such as diabetes. Eleotin is approved in many countries.
                          

For more information, visit
www.eastwoodcompanies.com www.medireport.com 
Or email us at info@eastwoodcos.com 

Thirty Percent of Canadians to be Diabetic by 2020

Thirty Percent of Canadians to be Diabetic by 2020

Did you know that November is Diabetes Awareness Month?  According to the Canadian Diabetes Association, 9 million people, nearly 1 in 4 Canadians, have diabetes or pre-diabetes.

More alarming figure is that thirty percent of Canadians will have diabetes or pre-diabetes by 2020.  On the occasion of Diabetes Awareness Month, CDA released the findings forecasting a 62 percent increase in the diagnoses and cost of diabetes over the next 10 years.  Pre-diabetes is a condition where blood glucose levels are higher than normal but not high enough to be diagnosed with diabetes.

Michael Cloutier, President of CDA says it’s largely due to changing demographics of the aging population and new ethnic communities.  It is estimated that the direct and indirect costs of diabetes in British Columbia will increase up to $1.9 billion per year by 2020.

The economic burden of diabetes represents only a part of the challenge.  The human cost of the disease is also reaching epidemic proportions.  There are currently 338,000 people, or 7.4 percent of the population, diagnosed with diabetes in BC.  It is not an exaggeration to say that diabetes is called the ‘Plague of the 21st Century.’

In order to offset the burden caused by diabetes, CDA demands that the government introduce an enhanced diabetes strategy through an independent review of current diabetes policies and programs.  Cloutier said that “turning the tide against diabetes requires a shift in government approach, private sector involvement and broad-based personal and societal change.”

CDA is also sponsoring events to help people with diabetes maintain healthy lives while they work to find a cure.  Canada has been the leading country in the area of diabetes research since the discovery of insulin by Dr. Frederick Grant Banting of the University of Toronto in 1921, one of the most important medical advances of the 20th century.

 

Eleotin is the only known 100% natural normalizer of long-term chronic metabolic disorders such as diabetes. Eleotin is approved in many countries.
                          

For more information, visit
www.eastwoodcompanies.com www.medireport.com 
Or email us at info@eastwoodcos.com

Best Diabetic & Hypertension Drug of the Year Award

Eleotin Wins ‘Best Diabetic Drug of the Year’ Award!

Eleotin, the world’s only known 100% natural normalization treatment for metabolic diseases, has been selected the winner of ‘Best Diabetic & Hypertension Management Drug of the Year 2010’ award by the government of Federal Republic of Nigeria.

The Institute for Government Research & Leadership Technology (IGRLT), a Nigerian state-run institution, announced on October 4 that Eleotin would be awarded the accolade for its contribution to the promotion of health of Nigerian people with its excellent efficacies concerning diabetes and hypertension.

Dr. Moses Essien, Country Director of the IGRLT said in his letter to Eastwood Bio-Medical Research Inc., the manufacturer of Eleotin, that “in the spirit of Nigeria’s 50th Independence celebration, the IGRLT has the honour to make this award go to Eleotin for having outperformed other products in the field of diabetic and hypertension pharmaceuticals in Nigeria.”

There were other motives that compelled the institute to give this award to Eleotin.  Dr. Essien stated the research revealed that the product has contributed to:

• Reduction of disease, unemployment, poverty, crime and other social vices
• Development of human capital and resources
• Growth of Nigeria’s economy

Some of the parameters and performance indicators that are looked at for this award are:

• Compliance with government regulatory laws and guidelines
• Efficacy of the product
• Product’s quality and value creation
• Product’s acceptability, satisfaction and endorsement
• Corporate general performance and track record

Eleotin has been distributed in Nigeria since it obtained the government approval as a pharmaceutical product (license number: A7-0179L) in 2007.  Nigeria, with the population of 140 million, has shown an explosive growth of diabetics as people are rapidly adopting Western lifestyles which are making them more prone to metabolic disorders.

The IGRLT, established in 2006, is a part of Nigeria Registered Project Initiative of the African Foundation.  Its council members include prestigious scholars in the field of economy, technology, and public policy.
(website: www.instituteforgovernmentresearch.com)

 

Eleotin is the only known 100% natural normalizer of long-term chronic metabolic disorders such as diabetes. Eleotin is approved in many countries.
                          

For more information, visit
www.eastwoodcompanies.com www.medireport.com 
Or email us at info@eastwoodcos.com

Is Moderate drinking beneficial to Diabetics?

Is Moderate drinking beneficial to Diabetics?

Following numerous studies which report that moderate drinking is beneficial, is this the case for diabetic patients? Or is there a risk to drinking alcohol ? and what is considered 뱈oderate?

Alcohol consumption has a negative effect on metabolism; alcohol metabolizes slowly and therefore must be controlled to prevent intoxication. The liver functions overtime to metabolize the alcohol and treats it as a poison, ridding itself of the toxin as quickly as possible, therefore postponing other more important functions such as utilization of fatty acids as fuel and storing excess fatty acids as triglycerides which causes a huge amount of fatty acid accumulation in the liver. Moreover, it causes the body to postpone converting stored carbohydrates into glucose, which may expose the body to low blood sugar levels? especially when combined with medications or insulin.

Meanwhile, studies have been conducted to determine how alcohol use affects the risk of, and management of diabetes. Among people without diabetes, moderate drinkers (1-3 drinks/day) developed 33-56% fewer cases of diabetes compared to non-drinkers. Heavy consumption (more than 3 drinks/day), however, was associated with a 43% increase of the risk in developing diabetes. In diabetics, moderate alcohol usage was associated with a 34-55% lowered incidence of coronary heart disease. However, researchers had concluded that more extensive studies in this area are needed to identify the long-term effects of alcohol on glucose and non-cardiac complications in diabetics.

DID YOU KNOW?
– Drinking alcohol causes an increase in blood pressure. If you suffer from hypertension it can contribute to kidney failure, heart disease and retinopathy.
– Alcohol impairs the liver뭩 ability to clear fat from the blood and increases triglyceride levels. You should not drink alcohol if you have high triglyceride levels (over 200 mg/dl).
– Alcohol is toxic to nerves. If you have neuropathy from diabetes in your arms, legs or feet, drinking alcohol can make it more severe.
– Alcohol moves quickly into the blood without being metabolized in your stomach. Within 5 minutes of drinking, there is enough alcohol in your blood to be measured, and it won뭪 peak until 30-90 minutes after you take a drink.
– Do not exercise before drinking and be cautious when dancing while you are drinking. You should always eat something when you ingest alcohol and keep a close eye on your blood glucose levels.
Obviously, abstention is advised for individuals with a history or alcohol abuse, pregnant women or people with medical issues such as liver disease, pancreatitis, advanced neuropathy, severe hypertriglyceridemia. The American Diabetes Association also notes that only observational studies and small trials have been reported on and therefore the data may not support recommending alcohol consumption for those at risk of, or with, diabetes. If such individuals consume alcohol, they should follow the recommendations set forth in the 2005 Dietary Guidelines for Americans which suggests no more than 1 drink per day for women and 2 per day for men. A 밺rink?according to these guidelines contains about 14 grams of alcohol and is defined as:
?nbsp;12 ounces of regular beer
?nbsp;5 ounces of wine
?nbsp;1.5 ounces of 80 proof distilled spirits
Eleotin and Alcohol
Alcohol seems to wash away the effects of Eleotin. Please be reminded that the effect of most of herbal medicines in general, not only Eleotin, gets washed away if you consume alcohol. Suggestion: let’s abstain from alcohol a few months. Once your health is fully improved, then, you can enjoy again. ( Opinions and Questions)

For more information, visit
www.eastwoodcompanies.com www.medireport.com 
Or email us at info@eastwoodcos.com

Next Avandia?

Next Avandia?

We all heard a lot about Avandia, a diabetes drug.  Many people died of heart attacks due to its side effects…

This is not an isolated incident for this particular diabetes drug.

This is a pattern that has been repeated for many years for many other diabetes drugs in the past and repeats many times in the future under different brand names by different manufacturers.

OK, the pattern:

1) A ‘sensational’ diabetes drug is ‘invented(?)’ by a major multi-national pharmaceutical company.  Its stock value goes up through the roof by many many billions of dollars.  The company spends billions of dollars to promote the new drug and every newspaper, TV station, and magazine in the world talks about it.  The company pays billions and billions of dollars to doctors who prescribe this drug.

2) The company usually makes 6-10 billions of dollars a year by selling the drug.

3) In 3-4 years, some deaths are reported and many (sometimes 7-8%) patients complain about many side effects.  But nobody pays attention.

4) Some doctors raise their voice.  But immediately, their opinions are silenced by famous diabetes scholars and prestigious universities whose conclusions are “No, it is not entirely conclusive, statistically abnormal hetero-stochastic outlying confidence level…”  Nobody knows what it really means.  True, that is exactly what they intended. Obfuscate.  The whistle blowers are persecuted and marginalized in academia for being skunks in a party in which everybody is having a great time.  Many argue that there are safer alternatives, but these people are derided and scorned.  Many people attack these doctors as ‘quacks’ and ‘un-scientific.’

5) Patients keep dying and pharmaceutical companies keep making billions of dollars.

6) The danger of the drug becomes an open secret.  Patients keep dying and pharmaceutical companies keep making billions of dollars.

7) Too many people begin to die to be kept as secret.  The deaths are reported to FDA.  FDA, rather than investigating the problems from a critical viewpoint, leaks the story, in a crony friendly way, I mean a quiet way, to the pharmaceutical company to get prepared for the potential future problem.  The drug company slowly activates the ‘exit plan’, which had already existed.

8) The company issues a statement that strongly argues that there is no danger.  They usually say that the wife of the president also uses the same drug.  Really?  Who cares?  Patients keep dying and pharmaceutical companies keep making billions of dollars.

9) Hundreds of thousands provable victims appear.  Then, only then, FDA starts investigations.  But, Patients keep dying and pharmaceutical companies keep making billions of dollars.

10) Massive class actions start.  The pharmaceutical company is found to have had the knowledge about the danger from the beginning.  FDA and scholars were found not really financially independent from the pharmaceutical company.

11) The pharmaceutical company drags the litigation on and on and on.  Settling some, fighting some.  The stock price usually goes down.  But, the stock price sometimes goes higher back when manipulated by some news provided by the pharmaceutical company.  In any way, by this time, original shareholders have already sold their shares long time ago, having realized the astronomical gains.  Billions of billions of dollars.

12) The stock price eventually goes down and down.  Then, the company is acquired by another pharmaceutical company.

13) After a few years, nobody remembers the name of the drug and the name of the company that does not exist anymore.

14) The above 1) starts under different names by different companies.

15) Then, the above 2

In our next few newsletters, we will show what are the next Avandia’s and how to protect yourselves from them.  Also, how would you know whether you were a victim, and if you are already a victim of these drugs, we will guide you how to get help.

Dr. Youngsoo Kim
CEO
Eastwood Bio-Medical Research Inc.

 

Eleotin is the only known 100% natural normalizer of long-term chronic metabolic disorders such as diabetes. Eleotin is approved in many countries.
                          

For more information, visit
www.eastwoodcompanies.com www.medireport.com 
Or email us at info@eastwoodcos.com 

New Discoveries on Brain Health

Be aware of high Potassium levels if you are diabetic

Be aware of high Potassium levels if you are diabetic

The kidneys are the filtering devices of the blood; they remove waste products from your body by producing and secreting urine. Urine may also contain sulfate and phenol waste, as well as excess sodium, potassium, and chloride ions. Among these, potassium is a very important mineral to help nerve conduction, help our heartbeat, and help our muscles contract.Low potassium can occur for many reasons. Use of water pills, diarrhea, and chronic laxative abuse are the most common causes of low potassium. Signs and symptoms of low potassium are weakness or tiredness, cramping in arm or leg muscles, nausea or vomiting, and irregular heart rhythms.

High potassium levels are often the result of kidney damage. Kidney damage is usually due to not only poorly controlled diabetes but also the incorrect usage of pharmaceutical drugs, especially those for diabetes and weight control. Too much potassium can lead to weakness, paralysis, irregular heartbeat, or even a heart attack. If you have diabetic kidney disease and your potassium levels are high (above 5.2), your health-care provider will likely recommend for you cut down on your potassium intake. Foods high in potassium include bananas, cantaloupe, sweet potatoes, tomatoes, and legumes which are regarded as healthy foods for diabetes and obesity.

Having kidney failure on top of having diabetes is bound to be overwhelming and confusing. To prevent it, we must be careful when selecting what we eat and drink. Most quick weight loss products are diuretics, inducing artificial, excess urination with huge side effects and the toxicity levels are terrible. The more toxic a diuretic is, the more powerful the weight loss effects become because the body wants to remove the toxin, resulting in more urination. In the process, kidney damage is inevitable.

When we originally formulated Eleotin, one of the first herbs tested was a traditional remedy for kidney diseases found in a Southeast Asian tribe. It is known to rejuvenate kidney functions and works wonders for diabetes and obesity problems as well. Testimonies of its effectiveness can be found on our website, with numerous people reducing the frequency or even stopping dialysis altogether after using Eleotin.

For more information, visit
www.eastwoodcompanies.com www.medireport.com 
Or email us at info@eastwoodcos.com 

Obesity is bad for your brain as well

Obesity is bad for your brain as well

A recent study published in the journal Human Brain Mapping compared the brains of obese, overweight and normal weight individuals. To define between the categories, scientists used BMI, or Body Mass Index, to establish that normal-weight people had a BMI between 18.5 and 25, overweight from 25 to 30, and obese over 30. Scientists discovered that obese individuals had 8% less brain tissue than normal weight people, and overweight people showed a brain tissue loss of 4%. Furthermore, when they compared both grey and white matter, obese people had lost more brain tissue in the frontal and temporal lobes, those critical for memory and planning. Also compromised were the anterior cingulated gyrus (attention and executive functions), basal ganglia (movement), and the hippocampus (long-term memory). Overweight individuals had loss mostly in the basal ganglia and parietal lobe, the sensory lobe.
The scientists also noted that the brains of obese people looked 16 years older than leaner people, and the overweight brains appeared to be 8 years older. This loss of tissue depletes cognitive reserves and put a person at greater risk for Alzheimer’s. This risk can be reduced by maintaining a healthy diet and lifestyle.